TITLE

Bronchodilation by an inhaled VPAC[sub2] receptor agonist in patients with stable asthma

AUTHOR(S)
Linden, A.; Hansson, L.; Andersson, A.; Palmqvist, M.; Arvidsson, P.; Lofdahl, C.-G.; Larsson, P.
PUB. DATE
March 2003
SOURCE
Thorax;Mar2003, Vol. 58 Issue 3, p217
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Investigates the effect of vasoactive intestinal peptide analogue Ro 25-1553 given by inhalation to patients with asthma. Methods; Lung function; Discussion.
ACCESSION #
9360829

 

Related Articles

  • vasoactive intestinal polypeptide.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2441 

    A definition of the term "vasoactive intestinal polypeptide (VIP)," which refers to a peptide present in the mucosa of the gastrointestinal tract, is presented.

  • VIP and watery diarrhoea.  // British Medical Journal;10/4/1975, Vol. 4 Issue 5987, p3 

    Focuses on vasoactive intestinal peptide and watery diarrhea syndrome. Recognition of the condition as a complication of functioning non-beta cell tumors; Significance of VIP estimations in diagnosis; Application of the syndrome to gastrointestinal disease.

  • VIP and Drug Design. Gozes, Illana; Furman, Sharon // Current Pharmaceutical Design;Feb2003, Vol. 9 Issue 6, p483 

    The following review outlines the physiological outcome of VIP and VIP gene manipulations. Previously, we reviewed the various VIP receptors associated with biological functions ranging from growth regulation, sexual function, bronchodilation, vasodilation and immune interactions to...

  • Role of androgens in women defined in early study. Hannapel, Coriene E. // Urology Times;Feb2001, Vol. 29 Issue 2, p43 

    Reports on the use of testosterone to enhance the reactivity of vaginal smooth muscle to vasoactive intestinal polypeptide (VIP) in animal models. Experiments that investigated the effects of androgen and estrogen replacement on the contractile responses of vaginal strips; Occurrence of...

  • Plasma endothelin, nitric oxide and atrial natriuretic peptide levels in humans after abdominal angiography. Murakami, R.; Machida, M.; Tajima, H.; Hayashi, H.; Uchiyama, N.; Kumazaki, T. // Acta Radiologica;May2002, Vol. 43 Issue 3, p340 

    Purpose: To clarify the effect of the contrast medium iopamidol on endothelial function and response of vasoactive peptide, as measured by changes in the levels of plasma endothelin, nitric oxide and atrial natriuretic peptide.Material and Methods: Thirteen patients...

  • Inhibitory Effect of Vasoactive Intestinal Peptide on the Challenge Phase of Allergic Contact Dermatitis in Humans. Lundeberg, L.; Mutt, V.; Nordlind, K. // Acta Dermato-Venereologica;5/27/99, Vol. 79 Issue 3, p178 

    There is increasing evidence that the nervous system has influence on the immune response. The effect of vasoactive intestinal peptide (VIP) and of serotonin and its antagonists on the challenge phase of allergic contact dermatitis in humans were tested. The substances were injected...

  • Role for VPAC2 Receptor--Mediated Signals in Pancreas Development. Rachdi, Latif; Marie, Jean-Claude; Scharfmann, Raphael // Diabetes;Jan2003, Vol. 52 Issue 1, p85 

    Mature pancreatic cells develop from progenitors that proliferate and differentiate into endocrine and exocrine cells. This development is thought to be controlled by secreted soluble factors acting on their target cells after binding to membrane receptors. Here, we analyzed the impact on...

  • Release of vasoactive intestinal peptide in the dumping syndrome. Sagor, G.R.; Bryant, M.G.; Ghatei, M.A.; Kirk, R.M.; Bloom, S.R. // British Medical Journal (Clinical Research Edition);2/14/1981, Vol. 282 Issue 6263, p507 

    Examines the release of vasoactive intestinal peptide (VIP) in dumping syndrome. Value of VIP concentration in patients with gastrectomy; Correlation between rate of rise in plasma VIP concentration and packed cell volume; Factor affecting the pathogenesis of dumping syndrome.

  • VIP: A very important protein in arthritis. Firestein, Gary S. // Nature Medicine;May2001, Vol. 7 Issue 5, p537 

    Describes how administration of the vasoactive intestinal peptide (VIP) suppresses inflammatory arthritis. Pathogenesis of rheumatoid arthritis; Action of mechanism of VIP; Potential beneficial effects of VIP in arthritis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics